Literature DB >> 30314816

Common and rare GCH1 variants are associated with Parkinson's disease.

Uladzislau Rudakou1, Bouchra Ouled Amar Bencheikh2, Jennifer A Ruskey3, Lynne Krohn1, Sandra B Laurent3, Dan Spiegelman3, Christopher Liong4, Stanley Fahn4, Cheryl Waters4, Oury Monchi5, Edward A Fon6, Yves Dauvilliers7, Roy N Alcalay8, Nicolas Dupré9, Ziv Gan-Or10.   

Abstract

GCH1 encodes the enzyme guanosine triphospahte (GTP) cyclohydrolase 1, essential for dopamine synthesis in nigrostriatal cells, and rare mutations in GCH1 may lead to Dopa-responsive dystonia (DRD). While GCH1 is implicated in genomewide association studies in Parkinson's disease (PD), only a few studies examined the role of rare GCH1 variants in PD, with conflicting results. In the present study, GCH1 and its 5' and 3' untranslated regions were sequenced in 1113 patients with PD and 1111 controls. To examine the association of rare GCH1 variants with PD, burden analysis was performed. Three rare GCH1 variants, which were previously reported to be pathogenic in DRD, were found in five patients with PD and not in controls (sequence Kernel association test, p = 0.024). A common haplotype, tagged by rs841, was associated with a reduced risk for PD (OR = 0.71, 95% CI = 0.61-0.83, p = 1.24 × 10-4), and with increased GCH1 expression in brain regions relevant for PD (www.gtexportal.org). Our results support a role for rare, DRD-related variants, and common GCH1 variants in the pathogenesis of PD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopa-responsive dystonia (DRD); GCH1; GTP cyclohydrolase 1 deficiency; Parkinson disease

Mesh:

Substances:

Year:  2018        PMID: 30314816      PMCID: PMC6251729          DOI: 10.1016/j.neurobiolaging.2018.09.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  34 in total

1.  GCH1 mutations are common in Serbian patients with dystonia-parkinsonism: Challenging previously reported prevalence rates of DOPA-responsive dystonia.

Authors:  Valerija Dobričić; Aleksandra Tomić; Vesna Branković; Nikola Kresojević; Milena Janković; Ana Westenberger; Vedrana Milić Rašić; Christine Klein; Ivana Novaković; Marina Svetel; Vladimir S Kostić
Journal:  Parkinsonism Relat Disord       Date:  2017-09-18       Impact factor: 4.891

2.  Rare GCH1 heterozygous variants contributing to Parkinson's disease.

Authors:  Qian Xu; Kai Li; Qiying Sun; Dongxue Ding; Yuwen Zhao; Nannan Yang; Yang Luo; Zhenhua Liu; Yuan Zhang; Chunrong Wang; Kun Xia; Xinxiang Yan; Hong Jiang; Lu Shen; Beisha Tang; Jifeng Guo
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.

Authors:  Yoshiaki Furukawa; James J Filiano; Stephen J Kish
Journal:  Mov Disord       Date:  2004-10       Impact factor: 10.338

Review 5.  Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.

Authors:  Dena G Hernandez; Xylena Reed; Andrew B Singleton
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

6.  Association of GCH1 and MIR4697, but not SIPA1L2 and VPS13C polymorphisms, with Parkinson's disease in Taiwan.

Authors:  Chiung-Mei Chen; Yi-Chun Chen; Mu-Chun Chiang; Hon-Chung Fung; Kuo-Hsuan Chang; Guey-Jen Lee-Chen; Yih-Ru Wu
Journal:  Neurobiol Aging       Date:  2015-12-30       Impact factor: 4.673

7.  Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome.

Authors:  V Leuzzi; Ca Carducci; Cl Carducci; F Cardona; C Artiola; I Antonozzi
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

8.  Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.

Authors:  Brian J O'Roak; Laura Vives; Wenqing Fu; Jarrett D Egertson; Ian B Stanaway; Ian G Phelps; Gemma Carvill; Akash Kumar; Choli Lee; Katy Ankenman; Jeff Munson; Joseph B Hiatt; Emily H Turner; Roie Levy; Diana R O'Day; Niklas Krumm; Bradley P Coe; Beth K Martin; Elhanan Borenstein; Deborah A Nickerson; Heather C Mefford; Dan Doherty; Joshua M Akey; Raphael Bernier; Evan E Eichler; Jay Shendure
Journal:  Science       Date:  2012-11-15       Impact factor: 47.728

9.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors:  Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal:  Nat Genet       Date:  2014-07-27       Impact factor: 38.330

10.  Beyond the Classic Segawa Disease, GCH1-Associated Neurodegenerative Parkinsonism: Practical Considerations for Physicians.

Authors:  Jirat Chenbhanich; Jirada Sringean; Roongroj Bhidayasiri
Journal:  J Mov Disord       Date:  2017-04-18
View more
  9 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 3.  Recognizing Atypical Dopa-Responsive Dystonia and Its Mimics.

Authors:  Philippe A Salles; Mérida Terán-Jimenez; Alvaro Vidal-Santoro; Pedro Chaná-Cuevas; Marcelo Kauffman; Alberto J Espay
Journal:  Neurol Clin Pract       Date:  2021-12

4.  Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.

Authors:  Uladzislau Rudakou; Eric Yu; Lynne Krohn; Jennifer A Ruskey; Farnaz Asayesh; Yves Dauvilliers; Dan Spiegelman; Lior Greenbaum; Stanley Fahn; Cheryl H Waters; Nicolas Dupré; Guy A Rouleau; Sharon Hassin-Baer; Edward A Fon; Roy N Alcalay; Ziv Gan-Or
Journal:  Brain       Date:  2021-03-03       Impact factor: 13.501

5.  Marginal BH4 deficiencies, iNOS, and self-perpetuating oxidative stress in post-acute sequelae of Covid-19.

Authors:  William A Villaume
Journal:  Med Hypotheses       Date:  2022-04-13       Impact factor: 4.411

6.  GCH1 Deficiency Activates Brain Innate Immune Response and Impairs Tyrosine Hydroxylase Homeostasis.

Authors:  Hannah Larbalestier; Marcus Keatinge; Lisa Watson; Emma White; Siri Gowda; Wenbin Wei; Katjusa Koler; Svetlana A Semenova; Adam M Elkin; Neal Rimmer; Sean T Sweeney; Julie Mazzolini; Dirk Sieger; Winston Hide; Jonathan McDearmid; Pertti Panula; Ryan B MacDonald; Oliver Bandmann
Journal:  J Neurosci       Date:  2021-12-07       Impact factor: 6.709

7.  MOSTWAS: Multi-Omic Strategies for Transcriptome-Wide Association Studies.

Authors:  Arjun Bhattacharya; Yun Li; Michael I Love
Journal:  PLoS Genet       Date:  2021-03-08       Impact factor: 5.917

8.  The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository.

Authors:  Ziv Gan-Or; Trisha Rao; Etienne Leveille; Clotilde Degroot; Sylvain Chouinard; Francesca Cicchetti; Alain Dagher; Samir Das; Alex Desautels; Janelle Drouin-Ouellet; Thomas Durcan; Jean-François Gagnon; Angela Genge; Jason Karamchandani; Anne-Louise Lafontaine; Sonia Lai Wing Sun; Mélanie Langlois; Martin Levesque; Calvin Melmed; Michel Panisset; Martin Parent; Jean-Baptiste Poline; Ronald B Postuma; Emmanuelle Pourcher; Guy A Rouleau; Madeleine Sharp; Oury Monchi; Nicolas Dupré; Edward A Fon
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.

Authors:  Hong-Xu Pan; Yu-Wen Zhao; Jun-Pu Mei; Zheng-Huan Fang; Yige Wang; Xun Zhou; Yang-Jie Zhou; Rui Zhang; Kai-Lin Zhang; Li Jiang; Qian Zeng; Yan He; Zheng Wang; Zhen-Hua Liu; Qian Xu; Qi-Ying Sun; Yang Yang; Ya-Cen Hu; Ya-Se Chen; Juan Du; Li-Fang Lei; Hai-Nan Zhang; Chun-Yu Wang; Xin-Xiang Yan; Lu Shen; Hong Jiang; Jie-Qiong Tan; Jin-Chen Li; Bei-Sha Tang; Ji-Feng Guo
Journal:  Transl Neurodegener       Date:  2020-08-04       Impact factor: 8.014

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.